Clinical trials
Diabetes Mellitus, Type 2 trials in Italy with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2013 | 3 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 45 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Azienda Ospedaliero-Universitaria Careggi | 3 |
| IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 3 |
| University of Milan | 3 |
| University of Pavia | 3 |
| University of Roma La Sapienza | 3 |
| Azienda Ospedaliero, Universitaria Pisana | 2 |
| Casa Sollievo della Sofferenza IRCCS | 2 |
| Antea Foundation | 1 |
| Antonio Rapacciuolo | 1 |
| Associazione Medici Endocrinologi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 45 |
| Diabetes Mellitus | 11 |
| Obesity | 4 |
| Hypertension | 3 |
| Albuminuria | 2 |
| Cardiovascular Diseases | 2 |
| Coronary Artery Disease | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Insulin Resistance | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.